Davita Inc vs Vanguard Real Estate Index Fund ETF — how do they compare? Davita Inc trades at $179.56 (market cap $11.29B), while Vanguard Real Estate Index Fund ETF trades at $90.12 (market cap $70.80B). The key difference: Vanguard Real Estate Index Fund ETF is far larger — about 6.3× Davita Inc's market cap, and Davita Inc is trading nearer its 52-week high, Vanguard Real Estate Index Fund ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Vanguard Real Estate Index Fund ETF for 112 Days on average.
| DVA | VNQ | |
|---|---|---|
Market Cap | $11.29B | $70.80B |
Volume | 582,204 | 6,073,580 |
Sector | Health | — |
52-Week High | $240.96 | $100.95 |
52-Week Low | $103.87 | $87.00 |
Typical Hold Time | 113 Days | 112 Days |
Enterprise Value | $24.01B | — |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, with a bearish technical signal and neutral oscillators. The company shows strong earnings beats in recent quarters with Q2 2026 EPS of $4.02 beating expectations of $3.88. Revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026, though net margins have fluctuated. Recent partnership expansion with Humana for value-based kidney care represents significant business development.
DVA presents a mixed outlook with 43% analyst buy ratings and a $235.67 price target suggesting 33% upside. However, high debt levels (65.55% debt-to-asset ratio) and regulatory risks in healthcare weigh on fundamentals. The stock's current valuation at P/E 15 and P/S 0.88 appears reasonable relative to earnings growth potential, making it attractive for value investors despite near-term bearish technicals.
VNQ trades at $90.02, up 1.5% today amid a bearish technical trend. The ETF faces pressure from rising Treasury yields, with moving averages signaling sell conditions. Recent news highlights institutional buying despite sector headwinds, as REITs grapple with interest rate sensitivity and valuation concerns. The dividend yield remains a focal point, though competition from T-bills challenges its income appeal.
Outlook: Near-term risks from Fed policy and sector rotation persist, but contrarian opportunities exist for long-term investors. Key risks include interest rate volatility and economic slowdowns, while potential upside hinges on rate stabilization and real estate demand recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →